Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/02/2006 | US20060246540 Monoclonal, humanized, fragmented or labeled antibodies; extracellular proteins; expression vectors; host cells |
11/02/2006 | US20060246525 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
11/02/2006 | US20060246524 Nanoparticle conjugates |
11/02/2006 | US20060246523 Antibody conjugates |
11/02/2006 | US20060246518 Compositions and methods for detection of sirolimus |
11/02/2006 | US20060246517 Epitope protection assay |
11/02/2006 | US20060246516 Method for detecting perilymphatic fistula |
11/02/2006 | US20060246506 Non-competitive immunoassay for small analytes |
11/02/2006 | US20060246502 Screening for a material that promotes or inhibits binding between a rabconnectin-3-binding protein having a specific amino acid sequence and rabconnectin-3 and therefore would be useful for regulating Ca2+-dependent exocytosis |
11/02/2006 | US20060246498 HNRPLL polypeptides, polynucleotides encoding same and compositions and methods of using same |
11/02/2006 | US20060246486 Human signal peptide-containing proteins |
11/02/2006 | US20060246483 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods |
11/02/2006 | US20060246465 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/02/2006 | US20060246461 Nucleotide sequence coding membrane protein; diagnosis of tumor, cancer |
11/02/2006 | US20060246456 Fucose transporter |
11/02/2006 | US20060246442 Using zinc transporter protein-8 to identify modulators for treatment and diagnosis of diabetic disorders |
11/02/2006 | US20060246430 Method and kit for the diagnosis or treatment control of intestinal carcinoma |
11/02/2006 | US20060246420 In vitro diagnostic test for enterovirus infections |
11/02/2006 | US20060246126 Therapeutic liposome composition and method of preparation |
11/02/2006 | US20060246125 Proteoliposome for use as gene transfer tool in treatment and diagnosis of cardiomyopathy, type II diabetes, Alzheimer's, Parkinson's diseases; gene therapy |
11/02/2006 | US20060246079 Neutralizing human antibodies to anthrax toxin |
11/02/2006 | US20060246078 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases |
11/02/2006 | US20060246077 Use of antibodies against the MUC18 antigen |
11/02/2006 | US20060246075 At least one variable region comprising at least one heavy chain and at least one light chain of selected amino acid sequences; vectors, host cells, transgenic animals or plants, diagnosis; Alzheimer's Disease |
11/02/2006 | US20060246071 Blood vessel specific immunoglobulins for use in prevention and treatment of cell proliferative disorders |
11/02/2006 | US20060246069 Inflammation and immunopathy caused by human anti-human Monocyte chemoattractant protein-1 |
11/02/2006 | US20060246068 Polypeptides having a triggering NK activity and biological applications |
11/02/2006 | US20060246066 Cleavable reagents for specific delivery to disease sites |
11/02/2006 | US20060246065 Fail molecules and uses thereof |
11/02/2006 | US20060246064 monoclonal antibodies; treat bone diseases characterized by changes in bone resorption, such as osteoporosis, hypercalcemia, bone loss due to arthritis metastasis, immobilization or periodontal disease, Paget's disease; denosumab |
11/02/2006 | US20060246062 Anti-ccr4 antibodies and methods of use therefor |
11/02/2006 | US20060246061 Method for generating monoclonal antibodies |
11/02/2006 | US20060246059 therapeutic protein comprising a tenth domain of fibronectin type III; protein scaffold; antibody design; scaffold derived from a fibronectin type III (Fn3) or Fn3-like domain, function like natural or engineered antibodies; antibody mimics designed for optimal folding, stability, and solubility |
11/02/2006 | US20060246058 Single-domain antigen-binding antibody fragments derived from llama antibodies |
11/02/2006 | US20060246056 Immunotherapy of rectal cancer |
11/02/2006 | US20060246051 Male reproductive disorders including proliferative disorders of testes |
11/02/2006 | US20060246032 Chimeric IL-10 |
11/02/2006 | US20060246004 Antibody variants and uses thereof |
11/02/2006 | EP1717316A1 Interferon-like protein ZCYTO21 |
11/02/2006 | EP1717315A2 Osteoprotegerin binding proteins and receptors |
11/02/2006 | EP1717314A1 Receptor for modified low-density lipoprotein |
11/02/2006 | EP1717310A1 Lineage-directed induction of human mesenchymal stem cell differentiation |
11/02/2006 | EP1717251A2 Methods of therapy for B-cell malignancies using human anti-CD40 antibodies |
11/02/2006 | EP1717250A1 Monoclonal antibody and use thereof |
11/02/2006 | EP1717248A1 Tumor targeted vector |
11/02/2006 | EP1717244A1 Akt activity specifically inhibiting polypeptide |
11/02/2006 | EP1716256A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
11/02/2006 | EP1716227A2 Methods of identifying putative gene products by interspecies sequence comparison and biomolecular sequences uncovered thereby |
11/02/2006 | EP1716181A2 Cdr-repaired antibodies |
11/02/2006 | EP1716180A2 Anti-ube4a/ufd2b polyclonal antibody and its use thereof as diagnostic and prognostic marker of 11q23 region alterations |
11/02/2006 | EP1716179A2 Monoclonal antibodies that specifically bind to folate receptor alpha |
11/02/2006 | EP1716178A1 Less immunogenic binding molecules |
11/02/2006 | EP1716176A2 Cd38 splice variants and uses thereof |
11/02/2006 | EP1716175A2 Protein ligands for nkg2d and ul16 receptors and uses thereof |
11/02/2006 | EP1716168A2 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma |
11/02/2006 | EP1716167A1 Cell surface marker |
11/02/2006 | EP1715892A2 Methods and compositions for modulating angiogenesis |
11/02/2006 | EP1715891A2 Methods of treating osteoarthritis with anti-il-6 or anti-il6 receptor antibodies |
11/02/2006 | EP1715890A1 Ctgf as target for the therapy of diabetic nephropathy |
11/02/2006 | EP1355946B1 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants |
11/02/2006 | EP1147137B9 Methods for generating phosphorylation site-specific immunological reagents |
11/02/2006 | EP1127130B1 Murine expression of human immunoglobulin lambda locus |
11/02/2006 | EP1107768B1 STABLE HYPOXIA INDUCIBLE FACTOR-1 alpha AND METHOD OF USE |
11/02/2006 | EP1003874B1 Neisseria lactoferrin binding protein |
11/02/2006 | EP0719331B1 Eotaxin = eosinophil chemotactic cytokine |
11/02/2006 | DE102005019845A1 New human antibody capable of human CD152 (CTLA-4) binding or an antibody fragment, useful for diagnosing or treating human diseases caused by over- and/or under-expression of CD152 |
11/02/2006 | CA2824855A1 Monoclonal antibodies and methods for their use in the detection of cervical disease |
11/02/2006 | CA2763805A1 P-cadherin antibodies |
11/02/2006 | CA2763671A1 P-cadherin antibodies |
11/02/2006 | CA2607475A1 Method for treating dementia or alzheimer's disease with a cd20 antibody |
11/02/2006 | CA2607455A1 Antibodies with immune effector activity and that internalize in endosialin-positive cells |
11/02/2006 | CA2607448A1 Tgf beta 1 specific antibodies |
11/02/2006 | CA2607444A1 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
11/02/2006 | CA2606250A1 Monoclonal antibodies and methods for their use in the detection of cervical disease |
11/02/2006 | CA2606222A1 Reagents that bind ccx-ckr2 |
11/02/2006 | CA2606196A1 Methods for treating lower motor neuron diseases and compositions for the same |
11/02/2006 | CA2606102A1 Modulation of antibody effector function by hinge domain engineering |
11/02/2006 | CA2605745A1 Cancer specific pcna isoform binding antibodies and uses thereof |
11/02/2006 | CA2605697A1 Method of producing human igg antibodies with enhanced effector functions |
11/02/2006 | CA2604786A1 Single-chain antibody with cleavable linker |
11/01/2006 | CN1856571A Method for linking sequences of interest |
11/01/2006 | CN1856508A Human monoclonal antibody fab fragments directed against HCV E2 glycoprotein and endowed with in vitro neutralizing activity |
11/01/2006 | CN1856507A Method of stabilizing antibody and stabilized solution-type antibody preparation |
11/01/2006 | CN1856505A Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
11/01/2006 | CN1856503A Peptide originating in hepatitis c virus |
11/01/2006 | CN1856325A Treatment of respiratory diseases with anti-IL-2 receptor antibodies |
11/01/2006 | CN1856324A Isolation of immunoglobulin molecules that lack inter-heavy chain disulfide bonds |
11/01/2006 | CN1854295A Production of specific micro-antibody for oarium cancer |
11/01/2006 | CN1854157A Antibodies to insulin-like growth factor i receptor |
11/01/2006 | CN1854156A Mono-cloning antibody of anti-human cancer protein iASPP and use thereof |
11/01/2006 | CN1853730A Modified cytokines for use in cancer therapy |
11/01/2006 | CN1282656C HIV peptides from conserved regions in GAGP 17 and 924 and their application in e.g. vaccines |
10/31/2006 | US7129341 Identification of Candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
10/31/2006 | US7129337 Hepatitis C virus (HCV) polynucleic acid of given nucleotide sequence unique to at least one of the new HCV subtypes 7,9,10 OR 11, OR TO SUBTYPES 1D, 1E, 1F, 1G, 2E, 2F, 2G, 2H, 2I, 2K, 2L,3G,4K OR 4M; producing recombinant polypeptide |
10/31/2006 | US7129332 Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof |
10/31/2006 | US7129330 Multivalent antibody constructs |
10/31/2006 | US7129327 Polypeptide and protein derivatives and process for their preparation |
10/31/2006 | US7129325 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative and tumor disorders |
10/31/2006 | US7129324 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
10/31/2006 | US7129213 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases |